drugset / Trial / NCT00378937

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain

NCT00378937

RandomizedOpen-labelSupportive care

Summary

RATIONALE: Oxycodone helps lessen pain caused by cancer and may improve quality of life. It is not yet known whether oxycodone works better and is more cost effective than standard therapy in treating patients with cancer pain. PURPOSE: This randomized phase IV trial is studying oxycodone to see how well it works compared with standard pain therapy in treating patients with cancer pain and if it is more cost effective than standard pain therapy.

Timeline

Start
2004-01
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule Oral
Subject Codeine Small molecule Oral
Subject Morphine Other / unclassified Oral
Subject Oxycodone Other / unclassified Oral
Subject dextropropoxyphene Unknown Oral